Zacks Research Has Pessimistic View of Clorox Q3 Earnings

The Clorox Company (NYSE:CLX) – Research analysts at Zacks Research lowered their Q3 2026 earnings per share estimates for shares of Clorox in a research note issued to investors on Tuesday, February 17th. Zacks Research analyst Team now anticipates that the company will earn $1.48 per share for the quarter, down from their previous estimate of $1.55. Zacks Research has a “Hold” rating on the stock. The consensus estimate for Clorox’s current full-year earnings is $7.15 per share. Zacks Research also issued estimates for Clorox’s Q4 2026 earnings at $2.23 EPS, Q2 2027 earnings at $1.56 EPS, Q3 2027 earnings at $1.56 EPS, FY2027 earnings at $6.74 EPS and Q2 2028 earnings at $1.69 EPS.

Clorox (NYSE:CLX) last issued its earnings results on Tuesday, February 3rd. The company reported $1.39 earnings per share for the quarter, missing analysts’ consensus estimates of $1.43 by ($0.04). The business had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a net margin of 11.17% and a return on equity of 383.01%. Clorox’s revenue for the quarter was down .8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.55 EPS.

Several other equities analysts have also recently commented on the stock. Royal Bank Of Canada set a $132.00 price target on shares of Clorox in a report on Wednesday, February 4th. Wells Fargo & Company set a $125.00 target price on Clorox in a research report on Tuesday. Jefferies Financial Group reduced their price target on Clorox from $152.00 to $151.00 and set a “buy” rating for the company in a report on Wednesday, February 4th. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a research note on Saturday, February 7th. Finally, Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research report on Friday, February 13th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and four have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Reduce” and a consensus target price of $118.73.

Clorox Stock Up 0.2%

Clorox stock opened at $123.24 on Thursday. Clorox has a twelve month low of $96.66 and a twelve month high of $159.04. The company has a debt-to-equity ratio of 71.03, a quick ratio of 0.48 and a current ratio of 0.74. The firm has a market cap of $14.90 billion, a PE ratio of 20.14, a P/E/G ratio of 0.61 and a beta of 0.59. The firm’s 50 day moving average price is $108.98 and its two-hundred day moving average price is $113.62.

Insider Buying and Selling

In other news, Director Pierre R. Breber bought 4,000 shares of the business’s stock in a transaction on Friday, November 21st. The stock was purchased at an average price of $104.13 per share, with a total value of $416,520.00. Following the transaction, the director directly owned 13,000 shares in the company, valued at approximately $1,353,690. The trade was a 44.44% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through the SEC website. 0.63% of the stock is owned by company insiders.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of the company. Total Investment Management Inc. acquired a new position in Clorox in the second quarter valued at about $25,000. Center for Financial Planning Inc. bought a new position in shares of Clorox in the third quarter valued at approximately $25,000. Vermillion & White Wealth Management Group LLC acquired a new position in shares of Clorox in the 3rd quarter worth approximately $25,000. NewSquare Capital LLC grew its position in Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after acquiring an additional 193 shares during the last quarter. Finally, Caitlin John LLC increased its holdings in Clorox by 1,807.1% during the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors and hedge funds.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.